Devon Equity Funds SICAV - European Opportunities I GBP AccRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | 14.7 | -8.9 | 11.5 | 0.4 | |
+/-Cat | - | -2.1 | 7.1 | -1.9 | -6.7 | |
+/-B’mrk | - | -5.4 | 4.1 | -1.9 | -8.4 | |
Category: Europe Large-Cap Growth Equity | ||||||
Category Benchmark: MSCI Europe Growth NR EUR |
Key Stats | ||
NAV 24/04/2024 | GBP 11.31 | |
Day Change | 0.41% | |
Morningstar Category™ | Europe Large-Cap Growth Equity | |
IA (formerly IMA) Sector | Europe Including UK | |
ISIN | LU2091191705 | |
Fund Size (Mil) 23/04/2024 | USD 34.57 | |
Share Class Size (Mil) 24/04/2024 | USD 34.96 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 05/10/2023 | 0.85% |
Investment Objective: Devon Equity Funds SICAV - European Opportunities I GBP Acc |
The investment objective of the Sub-Fund is to achieve long term capital growth by exploiting special investment opportunities in Europe. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Alexander Darwall 04/02/2020 | ||
James bird 01/10/2023 | ||
Inception Date 04/02/2020 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | MSCI Europe Growth NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Devon Equity Funds SICAV - European Opportunities I GBP Acc | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 9.57 |
RELX PLC | Industrials | 8.59 |
Experian PLC | Industrials | 8.48 |
Dassault Systemes SE | Technology | 6.54 |
Edenred SE | Financial Services | 5.33 |
Increase Decrease New since last portfolio | ||
Devon Equity Funds SICAV - European Opportunities I GBP Acc |